UPDATE 1-Cempra's lead oral antibiotic meets main goal in late-stage trial

(Adds details, CEO comment, share movement, analyst comments)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.